IRLAB Therapeutics
5.11.2021 08:07:05 CET | ACCESS Newswire | Press release
GOTHENBURG, SE / ACCESSWIRE / November 5, 2021 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA)
IRLAB Therapeutics AB (publ) will publish the interim report for the period January - September 2021 on Wednesday 10 November 2021 at 07:45 CET. A conference call will be held the same day starting at 10:30 CET, where CEO Nicholas Waters and CFO Viktor Siewertz will present the report. The presentation will be held in Swedish and will be followed by a Q&A session.
For those who wish to participate in the conference call, please dial:
SE + 46 850 558 373 or
UK + 44 333 300 9030
It is also possible to follow and listen to the presentation live on https://tv.streamfabriken.com/irlab-q3-2021
The presentation material will be available in Swedish and published in connection with the conference call on www.irlab.se , where the recorded version of the webcast will be available afterwards.
For more information
Åsa Hillsten, Head of IR & Corporate Communications
Mobile: +46 700 81 81 17
E-mail: asa.hillsten@irlab.se
About IRLAB
IRLAB is a Swedish research and development company that focuses on developing novel treatments in Parkinson's disease. The company's most advanced candidates, mesdopetam (IRL790) and pirepemat (IRL752), have completed Phase IIa studies and are designed to treat some of the most difficult symptoms related to Parkinson's disease: involuntary movements (PD-LIDs), psychosis (PDP) and symptoms linked to cognitive decline such as impaired balance and increased risk of falls (PD-Falls). Through the proprietary research platform, ISP (the Integrative Screening Process), IRLAB discovers and develops unique drug candidates for central nervous system (CNS)-related disorders where large and growing medical needs exist. In addition to the clinical candidates, the ISP platform has also generated several CNS programs that are now in preclinical phase. The project portfolio comprises a combination of the fully-funded mesdopetam program, run in collaboration with global partner Ipsen, as well as innovative in-house programs from preclinical to Phase IIb. IRLAB is listed on Nasdaq Stockholm Main Market. More information on www.irlab.se .
Attachments
Invitation to the presentation of IRLAB´s Interim report January - September 2021
SOURCE: IRLAB Therapeutics
View source version on accesswire.com:
https://www.accesswire.com/671344/Invitation-to-the-Presentation-of-IRLABs-Interim-Report-January-September-2021
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Stagwell (STGW) Appoints Nagmeh Taheri to Chief Growth Officer, Media & Commerce for Stagwell Europe16.10.2026 13:40:00 CEST | Press release
LONDON, UK / ACCESS Newswire / October 16, 2026 / Stagwell (NASDAQ:STGW), the global challenger network transforming marketing through AI, today announced the appointment of NagmehTaheri as Chief Growth Officer, Media & Commerce for Stagwell Europe, effective November 18, 2026. Reporting into James Denton-Clark, Chief Growth & Client Officer of Stagwell Europe, Taheri will oversee new business efforts across the European region for the Media & Commerce segment at Stagwell working specifically with sister media agencies Goodstuff and Stagwell Media. Taheri brings over 25 years of experience driving growth across some of the world's leading marketing holding companies, including WPP, Dentsu, Publicis Groupe, IPG and Omnicom. Widely recognised as one of the UK's foremost new business leaders, Taheri was ranked No. 1 in Campaign's UK Media New Business rankings in 2022 and 2024 and No. 3 in 2025. Throughout her career, she has built and led growth functions that have transformed how agency
Datavault AI Highlights Data Futures Platform Patent Amid Tokenized Stock Exemption15.10.2026 19:25:00 CEST | Press release
PHILADELPHIA, PA / ACCESS Newswire / October 15, 2026 / Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), a provider of data monetization, credentialing, digital engagement, and real-world asset ("RWA") tokenization technologies, today announced that the U.S. Patent and Trademark Office has issued a notice of allowance for its Method and System for Data Futures Platform patent application (U.S. Patent Application No. 17/441,847), and highlighted the relevance of the disclosed technology to a significant development in the regulatory landscape for tokenized securities. On September 17, 2026, the U.S. Securities and Exchange Commission announced a temporary, conditional "Innovation Exemption" intended to facilitate on-chain trading of certain tokenized National Market System stocks through qualifying Tokenized Securities Venues. The action represents a meaningful regulatory development for market participants exploring blockchain-based securities infrastructure, subject
Valsoft's TAG Software Group Acquires Positive Solutions, a UK Provider of Healthcare and Pharmacy Software15.10.2026 17:00:00 CEST | Press release
MONTRÉAL, QC / ACCESS Newswire / October 15, 2026 / Valsoft Corporation Inc. ("Valsoft"), a Canadian company specializing in the acquisition and long-term development of vertical market software businesses, today announced the acquisition of Positive Solutions Limited ("Positive Solutions"), a UK-based provider of pharmacy management and point-of-sale software for community pharmacies. The acquisition was completed through TAG Software Group, a wholly owned subsidiary of Valsoft. Founded in 1993 and headquartered in Adlington, UK, Positive Solutions provides integrated software that community pharmacies use to dispense medicine and run their retail operations. Its core products, Analyst PMR (patient medication record) and Analyst EPoS (electronic point of sale), support pharmacies ranging from single-site locations to large corporations. The company serves more than 2,500 sites across England, Scotland, and Wales. With this acquisition, TAG Software Group strengthens Valsoft's presence
OMP and Eastman Show Decision Velocity in Practice at Gartner Supply Chain Planning Summit 202615.10.2026 15:00:00 CEST | Press release
ATLANTA, GA / ACCESS Newswire / October 15, 2026 / OMP, a leader in AI-powered supply chain planning, is bringing Eastman to the Gartner Supply Chain Planning Summit 2026 in Denver, CO (November 2-3) to showcase decision velocity in practice. The global specialty materials company will show how it connected its long-term, mid-term, and short-term planning horizons into one cycle. Eastman on connecting its planning horizons In a session at the summit, Sachin Kothari, Manager IBP Excellence at Eastman, and Abhi Patel, Chief Business Operations Officer at OMP, will explain how Eastman moved from three planning horizons that each ran on their own schedule to one connected cycle linking long-, mid-, and short-term planning on a shared view of the value chain. The session also covers what got in the way of the shift and closes with the impact Eastman measured, along with recommendations for supply chain leaders whose planning still relies on handoffs. Meet OMP and explore planning transforma
Innodata to Report Third Quarter 2026 Results15.10.2026 14:05:00 CEST | Press release
NEW YORK, NY / ACCESS Newswire / October 15, 2026 / INNODATA INC. (Nasdaq:INOD) today announced that it will report Third Quarter 2026 results after the market closes on Thursday, November 5, 2026. A news release will be available in both the News and Investor Relations sections of the Innodata website, www.innodata.com. Innodata has scheduled an investor conference call for 5:00 PM Eastern time on that same day. The call-in numbers for the conference call are:(+1) 833 296 5777 North America, Toll Free(+44) 808 196 8935 United Kingdom(+1) 206 407 3228 InternationalParticipant Access Code 730 768 717 For Replay: (+1) 833 309 1852 North America-Toll Free(+44) 800 007 4044 United Kingdom(+1) 929 828 5978 InternationalAccess Code 730 768 717 Investors are also invited to access a live Webcast of the conference call at the Investor Relations section of Innodata's website at https://investor.innodata.com/events-and-presentations/. Please note that the Webcast feature will be in listen-only m
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom